EXPLORE THE DATA FOR DUPIXENT® (DUPILUMAB) ACROSS MULTIPLE PARAMETERS

 

Visit our virtual convention experience, which we created to provide a convenient means of communication with you during this pandemic. There, you will find a wealth of concise information on DUPIXENT and, it’s three indications.

Click below to interact with our virtual convention experience now:
dupixenthcp.com/virtualbooth

In our immersive virtual booth experience, you have the opportunity to:

  • Gain valuable insights from multiple experts
  • Delve into a video on the mechanism of action for DUPIXENT to glean a deeper understanding of how the drug works
  • Explore a treasure trove of helpful resources to enhance your knowledge
  • Access DUPIXENT MyWay® videos to provide support to your patients who are prescribed DUPIXENT
  • Learn more about dosing and administration options

Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We stand by the few who suffer from rare diseases and the millions with long-term, chronic conditions. With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation around the globe.

Regeneron is a leading biotechnology company that invents medicines for people with serious diseases. Founded and led for more than 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous US Food and Drug Administration–approved treatments, almost all of which were homegrown in our laboratories.

 

©2021 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.
DUPIXENT® and DUPIXENT MyWay® are registered trademarks of Sanofi Biotechnology.
11/2021 DUP.21.09.0486